Premium
COVID‐19: Some clinical questions after the first 4 months
Author(s) -
Bassetti Matteo,
Ansaldi Filippo,
Icardi Giancarlo,
Pelosi Paolo,
Robba Chiara,
Taramasso Lucia,
Trucchi Cecilia,
Vena Antonio,
Giacobbe Daniele Roberto
Publication year - 2020
Publication title -
european journal of clinical investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 107
eISSN - 1365-2362
pISSN - 0014-2972
DOI - 10.1111/eci.13326
Subject(s) - tocilizumab , medicine , cytokine release syndrome , cytokine storm , macrophage activation syndrome , immunology , hemophagocytic lymphohistiocytosis , concomitant , clinical trial , atypical pneumonia , randomized controlled trial , anakinra , disease , pneumonia , immune system , covid-19 , immunotherapy , chimeric antigen receptor , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom